Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells

Journal of Bone and Mineral Research

Volumn 12, Issue 3, 1997, Pages 439-446

  Takagi, Miki ^a   Kasayama, Soji ^a   Yamamoto, Takehisa ^a   Motomura, Takashi ^a   Hashimoto, Kunihiko ^a   Yamamoto, Hiroyasu ^a   Sato, Bunzo ^b   Okada, Shintaro ^a   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Nissei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ARTICLE; BONE METABOLISM; BONE REMODELING; GLUCOSE METABOLISM; GLYCATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; OSTEOPOROSIS; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS REGULATION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MATRIX; BONE RESORPTION; CELLS, CULTURED; DNA; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; MICE; NF-KAPPA B; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 0030899896     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.3.439     Document Type: Article

References (54)

1. Riggs BL, Melton LJ III 1986 Involutional osteoporosis. New Engl J Med 314:1676-1686.
2. Tohmé JF, Silverberg SJ, Lindsay R 1990 Osteoporosis. In: Becker KL (ed.) Principles and Practice of Endocrinology and Metabolism. Lippincott/East Washington Square, Philadelphia, PA, U.S.A., pp 491-504.
3. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG 1983 An interleukin-1-like factor stimulates bone resorption in vitro. Nature 306:378-380.
4. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR 1989 Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
5. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303.
6. Black K, Garrett IR, Mundy GR 1991 Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 128:2657-2659.
7. Girasole G, Passeri G, Jilka RL, Manolagas SC 1994 Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524.
8. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR 1986 Stimulation of bone resorption and inhibition of bone formation in-vitro by human tumor necrosis factors. Nature 319:516-518.
9. Johnson RA, Boyce BF, Mundy GR, Roodman GD 1989 Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124:1424-1427.
10. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu N, Stanley ER, Kurokawa T, Suda T 1993 Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257-263.
11. Schneider GB, Relfson M 1989 Pluripotent hemopoietic stem cells give rise to osteoclasts in vitro: Effect of rGM-CSF. Bone Miner 5:129-138.
12. Pacifici R 1996 Review: Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051.
13. Pacifici R, Rifas L, Titelbaum S, Slatopolsky E, McCracken R, Bergfeld M, Lee W, Avioli LV, Peck WA 1987 Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 84:4616-4620.
14. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
15. Pacifici R, Brown C, Rifas L, Avioli LV 1990 TNF-α and GM-CSF secretion from human blood monocytes: Effect of menopause and estrogen replacement. J Bone Miner Res 5:145 (abstract).
16. Pacifici R, Vannice JL, Rifas L, Kimble RB 1993 Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: Effect of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77:1135-1141.
17. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
18. Lips P, Courpron P, Meunier P 1978 Mean wall thickness of trabecular bone packets in human iliac crest: Changes with age. Calcif Tissue Res 26:13-17.
19. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Aranaud SB, DeLuca HF 1979 Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effect of age and dietary calcium. J Clin Invest 64:729-736.
20. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL 1983 Increase in serum bone γ-carboxyglutamic acid protein with aging in women. J Clin Invest 71:1316-1321.
21. Levin ME, Boisseau VC, Avioli LV 1976 Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. New Engl J Med 294:241-245.
22. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J 1988 Mineral metabolism and axial skeleton in diabetes mellitus. Diabetes 37:8-12.
23. Ishida H, Senio Y, Matsukura S, Ikeda M, Yawata M, Yamashita G, Ishizuka S, Imura H 1985 Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (non-insulin-dependent) diabetes. Metabolism 43:797-801.
24. Barrett-Connor E, Holbrook TL 1992 Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 268:3333-3337
25. van Dale PLA, Stolk RP, Bueger H, Algra D, Grobbee DE, Hofman A, Birkenhäger JC, Pols AP 1995 Bone density in non-insulin-dependent diabetes mellitus: The Rotterdam, study. Ann Intern Med 122:409-414.
26. Brownlee M, Cerami A, Vlassara H 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med 318:1315-1320.
27. Monnier VM, Kohn RR, Cerami A 1984 Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583-587.
28. Vlassara H, Blownlee M, Manogue KR, Dionarello CA, Pasagian A 1988 Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240:1546-1548.
29. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H 1990 Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of PDGF: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014.
30. Kirstein M, Aston C, Hintz R, Vlassara H 1992 Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 90:439-446.
31. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H 1989 Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407.
32. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ 1992 Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation endproducts is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873-2877.
33. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D 1993 Regulation of human mononuclear phagocytic migration by cell surface-binding proteins for advanced glycosylation end products. J Clin Invest 92:2155-2168.
34. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan Y-CE, Elliston K, Stern D, Shaw A 1992 Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004.
35. Tomasek JJ, Meyers SW, Basinger JB, Green DT, Shew RL 1994 Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Life Sci 55:855-861.
36. Miki S, Kasayama S, Miki Y, Nakamura Y, Yamamoto M, Sato B, Kishimoto T 1993 Expression of receptors for advanced glycosylation end products of renal cell carcinoma cells in vitro. Biochem Biophys Res Commun 196:984-989.
37. Sudo H, Kodama H-A, Amagai Y, Yamamoto S, Kasai S 1983 In vitro differentiation and calcification in a new clonal osteogenic cell line derived from new born mouse calvaria. J Cell Biol 96:191-198.
38. Yamamoto T, Ecarot B, Glorieux FH 1991 In vivo osteogenic activity of isolated human bone cells. J Bone Miner Res 6:45-51.
39. Labarca C, Paigen K 1980 A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102:344-352.
40. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
41. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu K, Tsunasawa S, Sakiyama F, Matsui H, Takahara T, Taniguchi T, Kishimoto T 1986 Complementary DNA for a novel human interleukin (BSF-2) that induce B lymphocytes to produce immunoglobulins. Nature 324:73-76.
42. Feinberg AP, Vogelstein B 1983 A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
43. Schreiber E, Matthias P, Müller MM, Schaffner W 1989 Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res 17:6419.
44. Shirakawa F, Chedid M, Suttles J, Pollok BA, Mizel SB 1989 Interleukin 1 and cyclic AMP induce K immunoglobulin light-chain expression via the activation of an NF-κB-like DNA-binding protein. Mol Cell Biol 9:959-964.
45. Wautier J-L, Wautier M-P, Schmidt A-M, Anderson GM, Hori O, Zoukourian C, Capron L, Chappey O, Yan S-D, Brett J, Guillausseu P-J, Stern D 1994 Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 91:7742-7746.
46. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D 1995 Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403.
47. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K-I 1990 Involvement of a NF-κB like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 10:561-568.
48. Vlassara H, Bucala R, Striker L 1994 Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151.
49. Brich MA, Ginty AF, Walsh CA, Fraser WD, Gallagher JA, Bilbe C 1993 PCR detection of cytokines in normal human and Pagetic osteoblast-like cells. J Bone Miner Res 8:1155-1162.
50. Sha WC, Liou H-C, Tuomanen EI, Baltimore D 1995 Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
51. McKinley D, Wu Q, Yang-Feng T, Yang Y-C 1992 Genomic Sequence and chromosomal location of interleukin-11 gene (IL-11). Genomic 13:814-819.
52. Mathiassen B, Nielsen S, Johansen JS, Hartwell D, Ditzel J, Rødblo P, Christiansen C 1990 Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabet Complications 4:145-149.
53. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928.
54. Fong Y, Edelstein D, Wang EA, Brownlee M 1993 Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats. Diabetologia 36:802-807.